MALAT1 and Hyperglycemia: The ARPE-19 cell line was used to confirm that hyperglycemia induced the expression of MALAT1 in vitro, and the corresponding expression of TNF-α, MCP-1, ICAM-1, and VEGF was also significantly increased, while the expression of these factors was significantly inhibited after silencing MALAT1.